Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues

Neoplasia

Volumn 4, Issue 2, 2002, Pages 141-150

  McDoniels Silvers, Amy L ^a   Stoner, Gary D ^b   Lubet, Ronald A ^c   You, Ming ^a,b,d  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer genes; cDNA microarray; Differential changes; Expression profile; Non small cell lung cancer

Indexed keywords

CELL ADHESION MOLECULE; CELL RECEPTOR; GROWTH FACTOR; RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

EID: 0036122839     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/neo/7900217     Document Type: Article

References (62)

1. Cancer statistics, 2001
2. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis
3. A genetic model for colorectal tumorigenesis
4. Hot spots for molecular genetic alterations in lung cancer
5. Role of p53 and apoptosis in carcinogenesis
6. Progress in understanding the molecular pathogenesis of human lung cancer
7. Expression of Bcl-2 oncogene protein is prevalent in small cell lung carcinomas
8. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation
9. Expression of Bcl-2-protein in small cell lung cancer
10. Bcl-2 protein in nonsmall-cell lung carcinoma
11. Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis
12. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer
13. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications
14. Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
15. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers
16. Multiple mechanisms of p161NK4A inactivation in non-small cell lung cancer cell lines
17. The biology of lung cancer
18. Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity
19. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
20. Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes
21. How many tumor suppressor genes are involved in human lung carcinogenesis?
22. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations
23. Advances in the analysis of chromosome alterations in human lung carcinomas
24. The biology of stem cell factor and its receptor C-kit
25. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene
26. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor
27. Growth-factor-dependent migration of human lung-cancer cells
28. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis
29. c-Src, receptor tyrosine kinases, and human cancer
30. The detection of the c-src protein gene product in human lung tumors
31. Synthesis and distribution of oncoproteins in tumor tissue
32. Activity of pp60c-src in 60 different cell lines derived from human tumors
33. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
34. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer
35. Expression patterns of immediate early transcription factors in human non-small cell lung cancer
36. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
37. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas
38. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator
39. Epidermal growth factor-related peptides and their receptors in human malignancies
40. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival
41. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity
42. Amphiregulin: A bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7
43. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung
44. Signal transfer by Eph receptors
45. Eph receptors and ephrins
46. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis
47. ELK and LERK-2 in developing kidney and microvascular endothelial assembly
48. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
49. Eph-related receptors and their ligands: Mediators of contact dependent cell interactions
50. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton
51. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
52. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
53. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
54. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis
55. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
56. Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas
57. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
58. Apoptotic index and apoptosis influencing proteins Bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma
59. Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins Bcl-2, mcl-1 and bax